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Multiple Sclerosis (MS) is a crippling chronic disease of the Central Nervous Sys-
tem caused by the presence of self-antibodies which progressively damage axonal 
myelin sheath, leading to axonal transmission impairment and to the development 
of neurological symptoms. MS is characterized by a Relapsing-Remitting course, and 
current therapies rely only on the use of immunosuppressive drugs, which are how-
ever unable to reverse disease progression. Encouraging results have been obtained 
in preclinical studies with the administration of Mesenchymal Stem Cells (MSCs) 
before disease onset (Zappia et al., 2005).
Here, we investigate the therapeutic potential of MSC administration after dis-
ease onset into an animal model of MS, represented by Dark Agouti rats affected by 
chronic Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (EAE) 
(Cavaletti et al., 2004).
106 MSC were intravenously injected in EAE rats after disease onset. Clinical score 
was assessed daily, and after 45 days rats were sacrificed and histological analysis of 
spinal cords performed to evaluate the demyelinating lesions.
After the first peak of disease, no further relapses were observed in EAE rats 
treated with MSCs, differently from what observed in EAE group.
Histological analysis demonstrated the presence of demyelinated plaques in spi-
nal cords of EAE rats, (Luxol fast Blue staining and anti-MBP immunohystochemis-
try). On the contrary the therapeutic schedule with MSCs significantly reduces the 
number and the extension of demyelinated areas in the spinal cords, confirming clini-
cal score evaluations. 
These results demonstrated that MSCs ameliorate the clinical course of EAE and 
hamper the disease relapsing by reducing the areas of demyelinated lesions.
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